Back to all webinars
BeiGeneius Hematology Summit – CLL
An expert multidisciplinary panel review the latest developments in CLL and the evolving role of BTK inhibitors via an interactive agenda including presentations, ‘Ask the Experts’ sessions and workshops.
Speakers
Patient evaluation and risk stratification
No entries
First-line treatment for CLL: An evolving landscape
No entries
Treating relapsed/refractory CLL
No entries
CLL and the immune system: Infections, vaccines, and autoimmune disease
No entries
Cardiovascular toxicities associated with BTK inhibitors
No entries
Updates in CLL from ASH 2022
No entries